Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2015 | The importance of targeting proliferating and quiescent cells in CLL

Peter Hillmen, MBChB, PhD from St. James’ University Hospital, Leeds, UK, discusses the importance of targeting proliferanting and quiescent chronic lymphocytic leukemia (CLL) cells.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, held in Orlando, FL.